Corresponding with this observation, TGF-beta downregulates several activating receptors in NK cells in the context of NSCLC and breast cancer [47, 59, 60], and plasma levels of TGF-beta inversely correlated with NKG2D expression in patients with lung or colon cancer [61]. Here, KLRK1 is linked to non-small cell lung carcinoma.